Company: ENTXW
Filing Date: 2025-05-30
Form Type: S-3
Source: 0001178913-25-002025
Chunk: 19

Company: Entera Bio Ltd.
Filing Date: 2025-05-30
Form: S-3
Chunk 19
---
 specifically pledged as security for, and dedicated solely to the benefits of the 
 holders of the debt securities of a series:                                                                                                                                                                                               |

| • | money in an amount; |

| • | U.S. government obligations; or |

| • | a combination of money and U.S. government obligations, |

in each case sufficient without reinvestment, in the written opinion of a nationally recognized firm of independent public accountants, to pay and discharge, and which shall be applied by the trustee to pay and discharge, all of the principal and interest at due date or maturity or if we have made irrevocable arrangements satisfactory to the trustee for the giving of notice of redemption by the trustee, the redemption date;

| • | we have delivered to the trustee an opinion of counsel stating that, under then applicable U.S. federal income tax law, the holders of the debt securities of that series will not recognize gain or loss for U.S. federal income tax purposes 
 as a result of the defeasance and will be subject to the same federal income tax as would be the case if the defeasance did not occur;                                                                                                         |

| • | no default relating to bankruptcy or insolvency and, in the case of a covenant defeasance, no other default has occurred and is continuing at any time; |

| • | if at such time the debt securities of such series are listed on a national securities exchange, we have delivered to the trustee an opinion of counsel to the effect that the debt securities of such series will not be delisted as a result 
 of such defeasance; and                                                                                                                                                                                                                        |

| • | we have delivered to the trustee an officers’ certificate and an opinion of counsel stating that all conditions precedent with respect to the defeasance have been complied with. |

We are required to furnish to each trustee an annual statement as to compliance with all conditions and covenants under the indenture. 13 DESCRIPTION OF WARRANTS We may issue warrants to purchase ordinary shares, debt securities, or other securities. We may issue warrants independently or together with other securities. Warrants sold with other securities may be attached to or separate from the other securities. We will issue warrants under one or more warrant agreements between our company and a warrant agent that we will name in the applicable prospectus supplement. Any such warrant agent will act solely as our agent in connection with the warrants of such series and will not assume any obligation or relationship of agency or trust with any of the holders of the warrants. The prospectus supplement relating to any warrants